Dynocardia, Inc.

In 2015, with the support of MIT and Tufts, the Dynocardia founding team began its search for a fundamentally new approach to continuously and automatically measure BP. After rigorous bench testing and ongoing clinical studies in the ICU, ViTrack technology has been proven to offer accurate and reliable continuous non-invasive blood pressure (cNIBP) monitoring of systolic and diastolic pressure—all in a wrist-worn device without the participation of the user, caregiver, or healthcare provider.